)
Mettler-Toledo International (MTD) investor relations material
Mettler-Toledo International UBS Global Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 performance and outlook
Q3 growth was 6%, with strength across industrial and laboratory products; industrial growth came on top of a double-digit core industrial comparison in the prior year.
Laboratory trends broadened from bioprocessing early in the year to QA/QC instruments in Q2 and liquid handling in Q3.
Q3 EPS grew 13% while investments in the business continued; initial 2027 outlook discussed at the event was ~5% local-currency revenue growth and low-double-digit earnings growth.
Management viewed market conditions entering 2027 as better than a year earlier, while remaining more cautious on Europe due to energy costs and investment patterns.
Regional demand and supply chain
Asia Pacific and China each grew 13% organically in Q3; China was tracking toward ~10% growth for the year, and management described the country as a strong long-term opportunity.
China advantages include a China-for-China footprint, local manufacturing, direct sales, and exposure to private companies; automation, digitalization, pharma, life sciences, and clean energy support demand.
Regional supply-chain investments over the past four years strengthened resilience and customer delivery; guidance assumes a return to previous IEEPA tariff rates, with substantially higher rates posing a different scenario.
More than half of production and QA/QC sales are in product categories positioned to benefit from U.S. onshoring; greenfield sites typically take 3–5 years to build, with most benefit expected as facilities are built out.
Long-term growth drivers
Long-term price realization baseline is ~2% in a normal inflation environment; elevated inflation may prompt additional pricing actions, supported by value proposition and innovation.
Hot segments, including semiconductors, data centers, batteries, and new materials, were described as a ~$250 million revenue opportunity growing at double digits; semiconductor and electrification investment trends may persist for years.
Service reaches about one-third of the serviceable installed base; each percentage point of added penetration contributes ~70 bps to total-company growth.
Management cited a good bolt-on acquisition pipeline in life sciences, software, service, and distribution, while emphasizing disciplined fit and confidence in organic growth.
- Long-term targets pair >6% sales growth with margin expansion and mid-teens EPS growth.MTD
Investor Day 2026 - Q3 sales rose 6% and adjusted EPS 13%; FY2026 EPS guidance increased.MTD
Q3 2026 - Q2 2026 delivered 4% sales growth, strong China gains, and raised full-year EPS guidance.MTD
Q2 2026 - Strong Q1 growth, tariff mitigation, and margin initiatives position the business for resilience.MTD
Bank of America 2025 Healthcare Conference - Q4 2025 delivered 8% sales and EPS growth, with a strong outlook for 2026.MTD
Q4 2025 - 2026 guidance targets 4% revenue growth, margin expansion, and full tariff mitigation.MTD
44th Annual J.P. Morgan Healthcare Conference - Q3 2025 delivered strong sales and EPS growth, with innovation and resilience amid tariff headwinds.MTD
Q3 2025 - Q2 sales fell 4% but net earnings rose 4% and full-year EPS guidance was raised.MTD
Q2 2024 - Q4 2024 saw double-digit sales and EPS growth, with 2025 guidance tempered by headwinds.MTD
Q4 2024
Next Mettler-Toledo International earnings date
Next Mettler-Toledo International earnings date
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
)
)